CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2
US Application 17/608,832
Filed on 2021-11-04
Filed on 2021-11-04
Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development
Canada
3139507
Filed on 2020-05-06
3139507
Filed on 2020-05-06
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION
Hong Kong
62022047561.5
Filed on 2022-02-04
62022047561.5
Filed on 2022-02-04
T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY
US Application 17/633,414
Filed on 2022-02-07
Filed on 2022-02-07
Chimeric Antigen Receptors Targeting CD-19
Japan
2021-215427
Filed on 2021-12-29
2021-215427
Filed on 2021-12-29
CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19
US Application 17/557,845
Filed on 2021-12-21
Filed on 2021-12-21
ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
Japan
2021-203953
Filed on 2021-12-16
2021-203953
Filed on 2021-12-16
Methods of Analyzing Virus-Derived Therapeutics
Macao
J/005746
Filed on 2022-01-19
J/005746
Filed on 2022-01-19
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON
The Netherlands
20150087.3
Filed on 2014-12-16
20150087.3
Filed on 2014-12-16